Canaccord Genuity on Telecommunications Equipment: Apple and Samsung Combine For 50% of Smartphone Sales
Get Alerts AAPL Hot Sheet
Price: $171.48 -1.06%
Rating Summary:
39 Buy, 25 Hold, 7 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Rating Summary:
39 Buy, 25 Hold, 7 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 11
Join SI Premium – FREE
Canaccord Genuity on Telecommunications Equipment: Apple and Samsung Combine For 50% of Smartphone Sales
Analyst, T. Michael Walkley, forecasted that during latter 2012 and for 2013, Samsung and Apple would consistently combine for more than half of smartphone unit sales.
Q2 estimate for Apple (Nasdaq: AAPL) 27 million units sold or approx. 17% market share. Q2 Samsung units sold at 49.3 million or approx. 31.1%. Total 48.1%
Q3 estimates for Apple at 24.0 million or 14.1%. Samsung at 55.5 million or 32.5%. Total 46.6%.
Q4'12 estimate for Apple at 50.0 million or 22.3%. Samsung at 66.6 million or 29.7%. Total market share 52%.
Walkley predicts that FY12 total will be approx. 49.7% between the two companies, and will rise to 52.3% in FY2013.
Analyst, T. Michael Walkley, forecasted that during latter 2012 and for 2013, Samsung and Apple would consistently combine for more than half of smartphone unit sales.
Q2 estimate for Apple (Nasdaq: AAPL) 27 million units sold or approx. 17% market share. Q2 Samsung units sold at 49.3 million or approx. 31.1%. Total 48.1%
Q3 estimates for Apple at 24.0 million or 14.1%. Samsung at 55.5 million or 32.5%. Total 46.6%.
Q4'12 estimate for Apple at 50.0 million or 22.3%. Samsung at 66.6 million or 29.7%. Total market share 52%.
Walkley predicts that FY12 total will be approx. 49.7% between the two companies, and will rise to 52.3% in FY2013.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple (AAPL) to Host Worldwide Developers Conference on June 10, 2024
- Apple (AAPL) option IV into hosting Worldwide Developers Conference (WWDC) online from June 10 through 14, 2024
- Can-Fite BioPharma (CANF) Reports FY23 Results, Issues Clinical Update
Create E-mail Alert Related Categories
Analyst Comments, Guidance, Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!